Who is sponsoring NCT05422495?

NCT05422495 is sponsored by University Hospital, Caen.

What drugs are being tested in NCT05422495?

Interventions in NCT05422495: training with Cycléo device (COTTOS ®),, non intervention.

What condition does NCT05422495 study?

NCT05422495 studies Fall Patients.

Is NCT05422495 still recruiting?

NCT05422495 is currently status unknown. Last updated 16 June 2022.

Last reviewed 2022-06-16 · How we verify

NCT05422495: GATE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Playful Cognitive-motor Mobility Training on Balance, Gait and Cognition and on the Prevention of Falls in Seniors

Status unknown NA Last updated 16 June 2022

What this trial tests

NA trial testing training with Cycléo device (COTTOS ®), in Fall Patients in 30 participants. Status unknown.

Timeline

26 January 2021

Primary endpoint
26 January 2023

26 January 2024

Quick facts

Lead sponsor	University Hospital, Caen
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	30
Start date	26 January 2021
Primary completion	26 January 2023
Estimated completion	26 January 2024
Sites	1 location across France

Drugs / interventions tested

training with Cycléo device (COTTOS ®),
non intervention (non-intervention) — full drug profile →

Conditions studied

Fall Patients — all drugs for Fall Patients →

Sponsor

University Hospital, Caen

Who can join

60 and older, any sex, with Fall Patients. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Falls in the elderly are the cause of considerable morbidity and mortality and constitute a public health problem with more than 9000 deaths in France among the over 65s following an accidental fall. Many scientific data suggest that regular physical activity has significant and long-lasting beneficial effects on the health of the elderly and is associated with better functional status, a lower risk of falls and improved cognitive functions. However, the attraction to physical activity fades over the years and the reasons mentioned by the elderly for a low practice of physical activity are multiple, the main one being the worsening of their state of health. The objective of this study is therefore to evaluate the impact of playful, motivating mobility training, stimulating both mobility and cognition, for 8 weeks, on the balance and mobility of elderly people in EHPAD, in particular in conditions of dual-task well known to be at high risk of falling, as well as on the prevention of falls.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Fall Patients

Currently open trials in the same condition.

NCT06175871 — New Clinical Rehabilitation Approach for the Management of Falls Risks · NA · recruiting
NCT05076565 — Wearable Airbag Technology to Mitigate Falls in Individuals With High Fall Risk · NA · active not recruiting

Other University Hospital, Caen trials

Trials by the same sponsor.

NCT07406737 — Feasibility and Outcomes Registry of Lumenless dEfibrillation Leads for Conduction System Pacing · not yet recruiting
NCT06639750 — Respiratory Microbioma and Respiratory Complications After Hematopoietic Stem Cell Transplantion · not yet recruiting
NCT07467031 — Bachstim Registry: a Feasability Study of Bachmann's Area Pacing · not yet recruiting
NCT07477132 — A Dose-response Study to Determine the Right Dosage of Sugammadex as a Reversal Agent of Rocuronium in Infants Between 1 · Phase 4 · not yet recruiting
NCT07520578 — EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WI · Phase 3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05422495 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Caen
Last refreshed: 16 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05422495.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing